Share on LinkedInShare on LinkedIn

ARTICLE · 07 NOVEMBER 2022

Market Intelligence Thought Leadership Award Winner

Nestle Facing Class-Action False Advertising Suit Over Boost Glucose Control Drinks

Nestle Healthcare Nutrition, Inc. is facing a class-action lawsuit over claims that its Boost Glucose Control drinks help diabetic consumers manage their blood sugar levels.

United StatesMedia, Telecoms, IT, Entertainment

Nestle Healthcare Nutrition, Inc. (Nestle) is facing a class-action lawsuit over claims that its Boost Glucose Control drinks help diabetic consumers manage their blood sugar levels. The case, Owen v. Nestle Healthcare Nutrition, Inc., was filed in New Jersey District Court. The suit alleges that Nestle makes druglike claims about the drinks, which have not been tested or approved by the Food and Drug Administration (FDA), and that the products mislead consumers into believing that the drinks help control blood glucose levels when in fact Nestle's own study revealed they do not.

False Advertising Allegations Against Nestle

Plaintiff Steven Owen's lawsuit involves Nestle's BOOST-brand Glucose Control over-the-counter drinks with the name "Glucose Control." As described in his complaint, the products are labeled "Glucose Control" and prominently state in bold, capitalized font that they "HELP MANAGE BLOOD SUGAR" and/or that they are "DESIGNED FOR PEOPLE

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from